Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

27.54USD
3:59pm EST
Change (% chg)

$-0.63 (-2.24%)
Prev Close
$28.17
Open
$27.95
Day's High
$28.17
Day's Low
$27.49
Volume
87,360
Avg. Vol
102,979
52-wk High
$29.54
52-wk Low
$7.50

CSII.OQ

Chart for CSII.OQ

About

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral... (more)

Overall

Beta: 2.43
Market Cap(Mil.): $918.42
Shares Outstanding(Mil.): 32.60
Dividend: --
Yield (%): --

Financials

  CSII.OQ Industry Sector
P/E (TTM): -- 34.58 29.35
EPS (TTM): -0.87 -- --
ROI: -22.77 12.41 12.97
ROE: -24.35 14.40 14.11

BRIEF-Cardiovascular Systems says Martha Goldberg Aronson joins board

* Cardiovascular systems announces healthcare veteran Martha Goldberg Aronson joins board of directors Source text for Eikon: Further company coverage:

Feb 21 2017

BRIEF-Cardiovascular Systems reports Q2 earnings per share $0.03

* Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

Jan 25 2017

BRIEF-Cardiovascular Systems says a stockholder derivative action was filed in United States district court against Co

* Cardiovascular systems -on may 10, 2016, a stockholder derivative action was filed in united states district court for district of minnesota against co

Nov 21 2016

BRIEF-Cardiovascular Systems Inc signs distribution agreement with Medikit Co., Ltd

* Press release - Cardiovascular systems, Inc. signs distribution agreement with Medikit Co., Ltd. for Japan Source text for Eikon: Further company coverage:

Nov 14 2016

BRIEF-Medikit gets exclusive distribution right of calcific lesions treatment device from CSI

* Says it reaches agreement with Cardiovascular Systems Inc , and gets exclusive distribution right of calcific lesions treatment device Diamondback360 produced by Cardiovascular Systems, in Japan market

Nov 11 2016

BRIEF-Cardiovascular Systems Q1 loss per share $0.06

* Cardiovascular systems, Inc. reports fiscal 2017 first-quarter financial results

Oct 26 2016

More From Around the Web

Earnings vs. Estimates